J.P. Morgan Healthcare Conference Spawns Strategic Partnerships, Collaborative Relationships for AscellaHealth, Reaffirms Market Focus on Specialty Drugs
Leaders ofAscellaHealth (Ascella), a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, returned from the recent 37th Annual J.P. Morgan Healthcare Conference buoyed by the receptivity among conference attendees to its corporate track record of bringing money back to payers and patients and re-engineering the pricing model, particularly with high cost specialty drugs. Ascella senior leadership points to recurrent conference themes as further confirmation of its corporate focus: addressing rising drug costs and the need for new models of pricing, with a huge focus on the role of intermediaries, like AscellaHealth, in the marketplace.
Dea Belazi, president and CEO, AscellaHealth, says, “We’re in the right place, at the right time with respect to the value we create in specialty drug pricing. Ascella’s discussions at JPM with strategic clients and potential partners validated the proprietary models and technology innovations that we offer. These meetings point to a very successful year ahead.”
As the largest and most informative healthcare investment symposium in the industry, the JPM conference provided an ideal setting for Ascella to conduct several introductory meetings with investment firms, as well as industry experts and thought leaders.
Bill Oldham, chairman and CFO, AscellaHealth, adds, “The interest level in our model and market solutions was palpable. Ascella’s high quality prescription drug management services along with other customizable services, such as carved-out specialty pharmacy services and cost-savings discount programs, meet customer expectations for extending discounts on prescription medications. This is a key differentiator of Ascella and contributes to our reputation as a best-in-class PBM, offering tailored, flexible and innovative solutions.”
By partnering with health plans, employer groups and unions, Ascella improves patient outcomes and better coordinates care.
Oldham continues, “We create value, especially in specialty drug pricing. This recent interest level further energizes our dedication to create custom benefit designs, maximize benefit plans and reduce costs.”
AscellaHealth, a national PBM serving commercial, Medicare and Medicaid segments offers high quality prescription drug management services along with other customizable services, such as carved-out specialty pharmacy services and cost-savings discount programs through its unique and proprietary service that extends discounts on prescription medications to customers more than any other PBM in the industry. Visit www.ascellahealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190205005124/en/